Clinical Trial Update: Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

BeiGene is conducting a Phase 1 study of BG-T187 both alone and in combination with other agents for advanced solid tumors, and recruitment is currently ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BG-T187

Snippet

Sponsor: BeiGene | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING